Long-term outcomes
Between the LH and OH groups, no significant difference was found in
12-, 36-, and 60-month overall survival (respectively, 88.5%, 82.9%,
and 71.8% vs. 83.7%, 74.3%, and 67.6%, p = 0.257) and disease-free
survival (respectively, 77.2%, 53.3%, and 48.3% vs. 71.5%, 52.8%,
and 39.7%, p = 0.509) (Figure 3A, B). In the favorable location
subgroup analysis, the F-LH and F-OH groups demonstrated no significant
difference in 12-, 36-, and 60-month overall survival (respectively,
90.7%, 88.1%, and 75.4% vs. 79.5%, 76.6%, and 70.4%, p = 0.184)
and disease-free survival (respectively, 79.2%, 52.9%, and 49.1% vs.
73.9%, 54.7%, and 39.5%, p = 0.683) (Figure 3C, D).